Market Overview

Benzinga's Top #PreMarket Losers

Share:
Related
Benzinga's Top Downgrades
UBS Downgrades Catamaran To Neutral
Related
Sarepta Therapeutics Announces New England Journal of Medicine Publication of Phase I Clinical Data of Marburg Drug Candidate, AVI-7288, Supporting Safety of the PMOplus® platform
Short-Sellers Betting Against These Biotechs

Catamaran (NASDAQ: CTRX) shares fell 9.27% to $47.00 in the pre-market trading after the company reported Q4 results.

Sarepta Therapeutics (NASDAQ: SRPT) dipped 4.89% to $28.01 after the company reported weaker-than-expected results.

Magic Software Enterprises (NASDAQ: MGIC) shares dropped 2.19% to $9.39 in pre-market trading after rising 6.31% on Wednesday.

InterMune (NASDAQ: ITMN) dipped 2.08% to $31.51 in the pre-market session after dropping 14.87% on Wednesday.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets

 

Related Articles (ITMN + CTRX)

Get Benzinga's Newsletters